We appreciate your participation in our continuing education activity. Your responses to this anonymous survey will allow us to improve our program offerings and services. Thank you for your time.
SECTION 1
Please use the scale below to rate the efficacy of the learning objectives, the presenters, and the instructional format:
        1 = Totally ineffective, wouldn't recommend
        2 = Somewhat ineffective, at least one serious deficiency

        3 = Somewhat effective, acceptable but not outstanding
        4 = Effective, meets high standards, would recommend

        5 = Highly effective, among the best

Question Title

* Rate the relationship between activity content to stated learning objective:

  2 3 4
Discuss epidemiological data on prevalence of depression and anxiety in late life in both community and nursing home settings.
Describe major medication classes used in the treatment of late-life anxiety and depression, including antidepressants, sedative-hypnotics, mood stabilizers and antipsychotics
Discuss unique features relevant to medication management in late-life, including comorbid dementia, medical problems, substance use, delirium, sensory deficits and psychosocial triggers.

Question Title

* Rate the effectiveness of the presenter, Andrew Rosenzweig, MD

  1 2 3 4 5
a. Presentation Style
b. Knowledge of Subject
c. Quality of Material
d. Practical applicability or relevance of topic
SECTION 2:
Using a rating scale of 0% (strongly disagree) to 100% (strongly agree), please indicate your level of agreement with each statement (1) BEFORE completing this educational activity and (2) AFTER completing the educational activity.

Question Title

* BEFORE completing this activity.......
a.  I KNOW about discuss epidemiologic data on prevalence of depression and anxiety in late life in both community and nursing home settings.

0%  Strongly disagree with statement 100%  Strongly agree with statement
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* b.  I am confident I can APPLY my knowledge to describe major medication classes used in the treatment of late-life anxiety and depression, including antidepressants, sedative-hypnotics, mood stabilizers and antipsychotics

0%  Strongly disagree with statement 100% Strongly agree
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* c.  I am confident I can APPLY my knowledge to discuss unique features relevant to medication management in late-life, including comorbid dementia, medical problems, substance use, delirium, sensory deficits and psychosocial triggers.

0%  Strongly disagree with statement 100% Strongly agree
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* AFTER completing this activity:
a. I KNOW about discuss epidemiologic data on prevalence of depression and anxiety in late life in both community and nursing home settings.

0% Strongly disagree 100% Strongly agree
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* b. I am confident I can APPLY my knowledge to describe major medication classes used in the treatment of late-life anxiety and depression, including antidepressants, sedative-hypnotics, mood stabilizers and antipsychotics

0%  Strongly Disagree 100% Strongly Agree
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* c. I am confident I can APPLY my knowledge to discuss unique features relevant to medication management in late-life, including comorbid dementia, medical problems, substance use, delirium, sensory deficits and psychosocial triggers.

0%  Strongly Disagree 100% Strongly Agree
Clear
i We adjusted the number you entered based on the slider’s scale.
SECTION 3:

Question Title

* What was the most significant thing(s) you learned today?

Question Title

* Do you intend to implement at least one practice improvement learned as a result of this learning activity?

Question Title

* Please feel free to share any additional comments and suggestions. Your feedback is extremely valuable to us. 

Question Title

* Are you interested in receiving continuing education credits?

Question Title

* If yes, what type of continuing education credit are you interested in?

Question Title

* Please enter your information (below) so we may send you a certificate

T